Mayne Completes Divestment Of US Generics To Dr Reddy’s
Indian Industry Giant Takes Control Of Australian Firm’s Generics Business
Executive Summary
Mayne Pharma and Dr Reddy’s have announced the completion of a deal that will see the Indian company take over the Australian firm’s US generics business.